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Abstract 1 
We have prepared and evaluated  about their the physico-chemical and biological properties of four 2 
different hyaluronated mesoporous silica nanoparticles (MSNs) samples (MSN/HA). Hyaluronic 3 
acid (HA) with two different molecular weights (200 and 6.4 kDa) was used for the conjugation of 4 
aminopropyl-functionalized MSN (NH2-MSN), following two different procedures. Namely, 5 
samples HA200A and HA6.4A were prepared by reacting activated HA with NH2-MSN (method 6 
A), while samples HA200B and HA6.4B were obtained carrying out HA activation in the presence 7 
of the nanoparticles (method B). The four samples showed similar hydrophilicity, but clear 8 
differences in the HA loading, textural properties, surface charge and stability of the suspensions. 9 
More in detail, conjugation using low molecular weight HA with method A resulted in low HA 10 
loading, with consequent scarce effects on dispersity and stability in physiological media. The 11 
highest yield and corresponding best performances were obtained with method B using high 12 
molecular weight HA. HA loading and molecular weight also influenced in a concerted way the 13 
biological response towards the MSNs of CD44 target cancer cells (CD44+) and control cells 14 
(CD44-): MDA-MB-231 and A2780, respectively. The absence of cytotoxicity was assessed. 15 
Moreover, the targeting ability of the best performing MSN/HA was confirmed by cellular uptake 16 
studies. 17 
 18 
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Graphical abstract 1 
 2 
 3 
Hyaluronated mesoporous silica nanoparticles (MSN/HA) are preferentially internalized in CD44+ 4 
tumor cells 5 
  6 
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1. Introduction 1 
Nanoparticles-based targeted therapy has emerged in recent years as an innovative strategy to 2 
maintain a drug therapeutic dose at the target site, while reducing systemic drug toxicity and 3 
adverse side effects to healthy tissues [1-3]. This approach is particularly important in relation 4 
to cancer therapy, where the differences in biochemistry between cancerous and normal tissues 5 
can be exploited for the selective targeting of over-expressed tumour specific receptors [4-7]. 6 
To this aim, nanomaterials are an ideal playground, thanks to their intrinsic properties such as 7 
high surface area, tuneable size and shape coupled to ease of synthesis and functionalization. 8 
Nanoparticles may be loaded with a plethora of bioactive molecules (e.g., small molecules, 9 
peptides, nucleic acids, etc.) to protect them from cleavage by external agents, thus the 10 
encapsulated drugs do not participate in the control over pharmacokinetic and biodistribution. 11 
Moreover, nanosize allows for permits passive transport in biological fluids and for establishing 12 
molecular interactions at the cellular and subcellular level [1]. 13 
Liposomes [8-10] and biodegradable polymeric nanoparticles [11-13] are among the most 14 
versatile biocompatible systems to encapsulate active ingredients. Mesoporous silica 15 
nanoparticles (MSNs) can be considered as their inorganic counterparts, with intrinsic features 16 
such as a huge available inner volume, inertness and chemical stability [14-17]. The ease of 17 
surface functionalization makes them ideal materials to develop “pharmaceutically adapted 18 
platforms” [18, 19], with great potentiality in relation to stimuli responsive applications [20-19 
26]. One of the major drawbacks for the systemic application of these nanosystems is their poor 20 
dispersity in biological fluids, which can be however improved by appropriate surface 21 
functionalization [19]. Functionalization (often carried out to optimize the interaction with the 22 
guest drug molecules) can be obtained with a variety of organosilanes, to optimize the 23 
interaction with the guest drug molecules [27]. This has important consequences on the surface 24 
properties, such as charge and hydrophilicity [28], which in turns can profoundly affect 25 
influence the nanoparticle cytotoxicity [29], cellular uptake, transport and/or fate in biological 26 
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fluids of the nanoparticles [30, 31]. 1 
Surface modification of nanocarriers through macromolecules is particularly relevant in the 2 
field of cancer treatment [32], where the conjugation of cytotoxic drugs with macromolecules is 3 
designed to improve their pharmacokinetic profile, prolonging the distribution and elimination 4 
phases [33]. The most employed are N-(2-hydroxypropyl) methacrylamide (HPMA), 5 
polyglutamate, human serum albumin, dextrans, heparin, chitosan, dendrimers, multi-arm 6 
polyethylene glycol (PEG), and hyaluronic acid (HA) [32, 33]. HA is a naturally-occurring 7 
glycosaminoglycan and a major component of the extracellular matrix. The HA receptor CD44 8 
is overexpressed in many cancer cells, and in particular in tumor-initiating cells. HA has thus 9 
attracted considerable interest in for the development of nanoplatforms for actively targeting 10 
drugs, genes, and diagnostic agents [34, 35]. 11 
In recent years, HA-conjugated MSN systems have been proposed in the literature, with the double 12 
effect aim to improve the MSNs dispersity and obtain a targeted delivery to CD44 overexpressing 13 
cancer cells [36-38]. Zhang et al. recently proposed biotin-modified HA coupled to MSN to enable 14 
controlled drug release at cancer cells expressing CD44 HA receptor CD44 [39]. Moreover, Chen et 15 
al. exploited used HA as both capping and targeting agent. In their work, the entrapped guest 16 
molecules were released from the inner pores of MSNs upon HA degradation in response to 17 
hyaluronidase-1, which occurred after receptor-mediated endocytosis into targeted cancer cells [40]. 18 
The potentiality of HA-conjugated MSN systems was further investigated by developing dual-19 
stimuli responsive systems. To this aim, the polysaccharide was conjugated to MSNs through a 20 
disulfide bond, which was cleaved in the presence of the high glutathione concentration 21 
characterizing cancer cells [23, 24]. Additionally, multifunctional “theranostic” materials where 22 
developed, coupling the above-mentioned properties to those of a gadolinium based bovine serum 23 
albumin complex for a concomitant simultaneous redox-responsive targeted drug delivery and 24 
magnetic resonance imaging [41]. 25 
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This work reports about In this work, the synthesis and characterization of hyaluronated MSNs 1 
(MSN/HA), which have been developed with the double aim to improve their dispersion in 2 
physiological media and their targeting ability. Here For the first time we compare different 3 
synthetic approaches, and the use of HA of different molecular weights (6.4 kDa and 200kDa), to 4 
identify the optimal strategy to obtain the better performances, both in terms of biological response 5 
and potential pharmaceutical application. A full physico-chemical description of the produced 6 
hybrid materials is given, including routine characterization, hydrophilicity analysis assessment, 7 
molecular and quantitative analysis of the HA external shell. Finally, the biological effects in 8 
cultured cells were studied and the results correlated to the materials properties.  9 
 10 
2. Experimental section 11 
2.1 Materials 12 
Cetyltrimethylammonium bromide (CTAB), tetraethyl orthosilicate (TEOS), sodium hydroxide 13 
(NaOH), (3-aminopropyl)-triethoxysilane (APTS) and all the other reagents and solvents were 14 
purchased from Sigma-Aldrich (Milan, Italy) and employed as received. Sodium hyaluronate (HA, 15 
of molecular weights MW 6.4 and 200 kDa) was purchased from Lifecore Biomedical (Chaska, 16 
MN). Fluorescein-5-isothiocyanate (FITC) was provided by Invitrogen (Life Technologies, Monza, 17 
Italy). MilliQ® water was used in all synthetic steps. 18 
 19 
2.2 NH2-MSN synthesis 20 
MSN samples were prepared following a slightly modified literature procedure [42, 43]. CTAB (1 21 
g, 2.74 mmol), employed as Structure Directing Agent (SDA), was dissolved in 480 ml of water 22 
under stirring and heating. At the stable temperature of 80°C, NaOH (2.0 M, 3.5 ml) was slowly 23 
added to the mixture. TEOS (5 ml, 22.4 mmol) was then added dropwise drop-wise over 10 min 24 
under vigorous stirring. After 2 h of stirring at 80 °C the milky reaction mixture was cooled to room 25 
temperature (RT) and the white precipitate was filtered off and washed with abundant water and 26 
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methanol. The SDA was removed from the as-synthesized material by calcination at 550 °C, 1 
heating to the desired temperature under N2 flow and switching to O2 for a 6 h isotherm. 2 
Aminopropyl-functionalized MSN (NH2-MSN) sample was prepared with APTS by post-synthesis 3 
grafting with a procedure modified from the literature [44, 45]. Namely, 1 g of MSN (overnight 4 
dried at 100°C) were suspended in 30 ml of anhydrous toluene. The particles suspension was heated 5 
at 130°C under stirring. Next, 0.6 ml of APTS were added drop-wise and the mixture was allowed 6 
to reflux for 17 h. The modified NH2-MSNs were filtered off and washed with toluene, ethanol, 7 
water and at last finally methanol. Subsequently, the sample was dried at 110°C for 3 h to favor the 8 
for curing, and at 80°C overnight [46]. 9 
 10 
2.3 Hyaluronic acid conjugation: MSN/HA samples 11 
Conjugation with HA was carried out starting from NH2-MSN, to exploit the aminopropyl 12 
functionality for covalent linking of the targeting agent. We followed three different procedures 13 
proposed in the literature [36, 37, 40]. The protocol described in Ref [40] was discarded since the 14 
prepared samples resulted in the lowest derivatization yield. This is probably ascribable to the low 15 
concentration of the coupling agent 1-ethyl-3-(3ʹ-dimethylaminopropyl)carbodiimide (EDAC), 16 
notwithstanding the excess of HA with respect to MSN. The methodologies proposed by Yu et al. 17 
and by Ma et al. [36, 37], briefly described below, are hereafter mentioned as method A and B, 18 
respectively. HA of MW of 6.4 and 200 kDa were used with each method for both preparations. 19 
 20 
2.3.1 Samples HA200A and HA6.4A 21 
This approach requires activation of HA through N-hydroxysuccinimide (NHS) and EDAC as 22 
coupling agent, before nanoparticles conjugation [37]. To this aim, 56 mg of NHS and 30 mg of 23 
EDAC were separately dissolved in 1.5 ml water, each. 17 mg of HA were suspended in 9 ml water, 24 
before adding the NHS and EDAC solutions previously prepared. The mixture was left under 25 
magnetic stirring at RT for 1 h. 150 mg of NH2-MSN were suspended by sonication in 15 ml of 26 
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water, before adding the activated HA solution. pH was then adjusted to 9 with trimethylamine 1 
(TEA). The mixture was heated to 38 °C and left under stirring overnight. After cooling down to 2 
RT, the supernatant was separated by centrifugation (60 rpm, 20 min). The solid powdered product 3 
was washed thrice with water, and suspended in few ml of water before freeze-drying. This 4 
procedure was carried out with HA 200kDa and 6.4 kDa, resulting in samples HA200A and 5 
HA6.4A, respectively.  6 
 7 
2.3.2 Samples HA200B and HA6.4B 8 
With this method, Following method B, activation of HA was carried out directly in the presence of 9 
the nanoparticles. 150 mg of NH2-MSN were sonicated in 30 ml of 2-(N-10 
morpholino)ethanesulfonic acid (MES) buffer 0.01 M, at pH 6. 150 mg of HA were dissolved in 15 11 
of ml of MES and added to the nanoparticles suspension. 15 mg of EDAC and 15 mg of NHS, each 12 
dissolved in 7.5 ml of MES, are were added to the MSN suspension. The reaction was kept under 13 
magnetic stirring at RT for 4 h and successively centrifuged (60 rpm, 20 min). After removal of the 14 
supernatant, the solid powdered product was washed thrice with water and re-suspended in few ml 15 
of water for freeze-drying [36]. The procedure was carried out with HA 200kDa and 6.4kDa, 16 
resulting in samples HA200B and HA6.4B, respectively.  17 
 18 
2.3.3 Fluorescent labelling 19 
FITC labelled NH2-MSN and MSN/HA samples were prepared as reported in Ref. [37] with minor 20 
modifications. Briefly, 250 µl of FITC ethanol solution (0.3 mg/ml) were added at to a suspension 21 
of 1 mg of MSN in 150 µl of water 250 µl of FITC ethanol solution (0.3 mg/ml) were added. The 22 
mixture was maintained at RT for 6 h under stirring in the dark and then the nanoparticles were 23 
centrifuged (60 rpm, 10 min) and washed with ethanol thrice until the supernatants were colorless. 24 
 25 
2.4 Physico-chemical characterization 26 
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High Resolution Transmission Electron Microscopy (HRTEM) analyses were performed by means 1 
of measurements were carried out with a JEM 3010-UHR microscope (JEOL Ltd.) operating at 300 2 
kV. For the measurements, p Powders were dispersed on a copper grid coated with a perforated 3 
carbon film. The size distribution of the samples was obtained by measuring a statistically 4 
representative number of particles (ca. 250 particles).and the The results are indicated as mean 5 
particle diameter (dm) ± standard deviation (STD) (dm±STD). 6 
Specific surface area (SSA), cumulative pore volume and pore size distribution of samples were 7 
calculated by gas-volumetric analysis measuring N2 adsorption-desorption isotherms at liquid 8 
nitrogen temperature (LNT) using an ASAP 2020 physisorption analyser (Micromeritics). The SSA 9 
was calculated by the Brunauer-Emmett-Teller (BET) method and the average pore size was 10 
determined by means of the Barrett-Joyner-Helenda (BJH) method, employing Kruk–Jaroniec–11 
Sayari (KJS) equations on the adsorption branch of nitrogen isotherms. Before the measurement, 12 
the samples were outgassed at RT overnight. 13 
Powder X Ray Diffraction (PXRD) patterns were collected with a PW3050/60 X’Pert PRO MPD 14 
diffractometer (Panalytical) working in Bragg–Brentano geometry, using Cu Kα radiation (40 mA 15 
and 45 kV), with a scan speed of 0.0167° min-1 and a measure time of 200 s/step. The measure was 16 
carried out at low angles, in the range of 1.5-12°. 17 
Thermogravimetric analysis (TGA) was carried out on a Q600 analyzer (TA Instruments) heating 18 
the samples at a rate of 10 °C/min from RT to1000°C in air flow. Before starting measurements, 19 
samples were equilibrated at 30°C. 20 
Fourier Transform Infrared (FTIR) spectra were recorded using an IFS28 spectrometer (Bruker 21 
Optics) equipped with a MCT detector, working with a resolution of 4 cm-1 over 64 scans. The 22 
spectra were obtained in transmission mode, with the samples pressed in the form of self-supporting 23 
pellets, mechanically protected with a pure gold frame. Samples were placed in quartz cells 24 
equipped with KBr windows, allowing in situ activation and measurement. Before spectra 25 
measurement the samples were outgassed at RT for 4 hours to remove adsorbed water and 26 
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impurities. Spectra were normalized with respect to pellet thickness for direct comparison, by using 1 
the silica overtone modes in the 2100-1500 cm-1 interval. 2 
Colorimetric carbazole test was carried following the procedure described in [47]. Briefly, a 3 
suspension of 4 mg/ml in water was prepared for each sample. Two aliquots (60 and 180 µl) were 4 
diluted to a final volume of 1 ml in water. 3 ml of a 0.025 M Na2B4O7·in H2SO4 96% solution were 5 
added to each tube. The suspensions were then shaken and heated at 100°C for 10 min. After 6 
cooling down, 100 µl of a carbazole solution 0.1% p/v in absolute ethanol was added, before 7 
mixing and heating again at 100°C for 10 min. After cooling down, absorbance was measured at 8 
530 nm using a DU-70 Beckman spectrophotometer. 9 
Microgravimetric H2O adsorption/desorption isotherms were measured with an intelligent 10 
gravimetric analyzer (IGA-002, Hiden Analytical), based on an ultrahigh-vacuum (UHV) 11 
microbalance (weighing resolution of 0.2 µg) with integrated temperature and pressure control. 12 
Temperature control was based on a thermostated water bath/circulator, while pressure control was 13 
achieved with a Baratron capacitance manometer (accuracy ± 0.05 mbar). Buoyancy corrections 14 
were carried out using the weights and densities of all the components of the sample (including 15 
adsorbed phase) and counterweight sides of the balance, and the measured temperature. The mass 16 
uptake was measured as a function of time, and the approach to equilibrium of the mass relaxation 17 
curve was monitored in real time using a computer algorithm (real time processor, RTP). For each 18 
isotherm point the time origin of real-time analysis was set at 75% of the pressure change, while the 19 
minimum and maximum data collection time were set to 5 and 60 mins, respectively. RTP uses last-20 
squares regression of a linear driving force (LDF) model in order to extrapolate a value of the mass 21 
relaxation asymptote and assess the time-scale of interaction. The samples were loaded in a sealed 22 
stainless steel reactor, where they were outgassed at 50°C overnight prior to H2O dosage, in order to 23 
measure the sample dry weight. Two consecutive adsorption/desorption isotherms were measured 24 
varying the water equilibrium pressure in the 0-20 mbar interval (step of 3 mbar) at 28 °C. This 25 
corresponds to a maximum p/p0 value around 0.55 (p0@38 mbar at the measurement temperature). 26 
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The experimental isotherms were analyzed with a Langmuir model, which assumes a monolayer 1 
adsorption onto the surface and is expressed by the equation: 2 𝑞 = #$%	'()%	'  (1) 3 
where q is the equilibrium water uptake, qm is the adsorption capacity (corresponding to the 4 
monolayer saturation) and K the Langmuir constant, which corresponds to the adsorption 5 
equilibrium constant [48]. qm and K were calculated via the linearization of the Langmuir equation, 6 
as follows: 7 
'# = 	 (%	#$ +	 '#$  (2) 8 
Calculations were carried out expressing the equilibrium pressure as p/p0, so that the K values 9 
reported in Table 4 are dimensionless. 10 
The mean hydrodynamic size was determined at 25°C by Dynamic Light Scattering (DLS) using a 11 
nanosizer (Nanosizer Nano Z, Malvern Inst., Malvern, UK). The selected angle was 173° and the 12 
measurement was taken carried out after dilution of the nanoparticle suspensions in water and in 13 
phosphate buffered saline (PBS 0.1 M, pH = 7.4). The particle surface charge was investigated by 14 
zeta potential measurements at 25°C in water and PBS solution applying the Smoluchowski 15 
equation and using the NanosizerNanoseries Zetasizer Nanoseries ZS 90 (Malvern Instruments.). In 16 
both cases, measurements were carried out in triplicate by diluting 80 µl of a 1mg/ml particles 17 
suspension in water with the selected medium, to reach a final volume of 1 ml. 18 
For the dispersity test 2 mg of NH2-MSN and MSN/HA samples were added to 1 ml of different 19 
medium [PBS 0.1 M or Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% of 20 
fetal bovine serum (FBS)] and bath sonicated for 30 min. then dispersity The stability of the 21 
dispersions was evaluated after 0, 4, 8, 24 and 30 h was evaluated. 22 
 23 
2.5. Tumour cell lines culture 24 
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MDA-MB-231 (human breast adenocarcinoma) and A2780 (human ovarian carcinoma) cells were 1 
used. MDA-MB-231 cells were grown in DMEM supplemented with 10% of FBS, 0.03% of L-2 
glutamine and 2% penicillin and streptomycin. A2780 cells were cultured in RPMI 1640 medium 3 
containing 10% FBS, 0.03% of L-glutamine, 2% penicillin and streptomycin, and 50 g/ml of 4 
gentamicin sulfate. Cells were maintained in a humidified incubator at 37°C in 5% CO2. 5 
 6 
2.6. Receptor expression analysis 7 
Flow cytometry was used to determine the presence of CD44 on the cell surface by indirect 8 
immunofluorescence. Cells were washed twice with PBS and incubated 30 min in the dark at 4 °C 9 
with CD44 primary antibody, washed twice with PBS and then incubated 30 min in the dark at 4 °C 10 
with a phycoerythrin (PE) conjugated goat antibody (Dako Italia, Milan, Italy). Samples were 11 
analyzed on a flow cytometer instrument (FACSCanto, Becton Dickinson, San Jose, CA). Dead 12 
cells and debris were excluded on the basis of forward-scatter and side-scatter. Flow cytometry data 13 
were analyzed using the FlowJo software (TreeStar, Ashland, OR). CD44 expression was measured 14 
by calculating the ratio between median fluorescence intensity of cells labelled with antibodies 15 
versus unlabelled cells (Relative Median Fluorescence Intensity, RMFI). 16 
 17 
2.7. Incubation with MSN and cytotoxicity evaluation  18 
MDA-MB-231 and A2780 cells were seeded at 1 x 104 cells/well in 96 wells microtiter plates and 19 
incubated overnight to allow cellular adhesion. Various dilutions of NH2-MSN and MSN/HA 20 
samples (1.5-25 µg/ml) were added in triplicate, and incubated for 24, 48 and 72 h. 21 
Cell growth inhibition was evaluated by sulforhodamine B (SRB) colorimetric proliferation assay, 22 
modified by Vichai and Kirtikara [49].  23 
 24 
2.8 Confocal analysis of fluorescent MSN 25 
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After 24 h incubation with either FITC labelled NH2-MSN or MSN/HA, MDA-MB-231 and A2780 1 
cells were fixed for fluorescence microscopy with 4% (v/v) paraformaldehyde in PBS, pH 7.4, for 2 
30 min at room temperature. The samples were stained for DNA with Hoechst 33342 (1 µg/ml in 3 
PBS for 5 min; Sigma), counterstained with 0.1% Trypan blue in PBS for 30 sec to visualize the 4 
cytoplasm, rinsed in PBS, and mounted in a 1:1 mixture of glycerol:PBS (Calbiochem, Inalco, 5 
Milan, Italy). For confocal laser scanning microscopy (CLSM), a Leica TCS SP5 AOBS system 6 
(Leica Microsystems Italia, Milan, Italy) was used with a 40x oil immersion objective. For 7 
fluorescence excitation, a diode laser at 405 nm for Hochest, an Ar laser at 488 nm for FITC and a 8 
He/Ne laser at 543 for Trypan blue were employed. Z-stack of 1.5 µm step sized images (each 9 
image in the 1024x1024 pixel format) were collected and processed by the Leica confocal software. 10 
The RGB channels of the images presented here are the gray intensity images obtained with 405 nm 11 
(B), 488 nm (G) and 533 nm (R) excitation wavelengths respectively. 12 
 13 
2.9 Cellular uptake 14 
A quantitative determination of the cellular uptake was performed on a fluorescence-activated cell 15 
sorter (FACS). MDA-MB-231 and A2780 cells seeded in 6-well culture plates (5X105 cells/well), 16 
were exposed for different length of time (15 min, 30 min or 1 h) to FITC labelled NH2-MSN and 17 
MSN/HA with equivalent fluorescence. After removal of the free FITC-NH2-MSN and FITC-18 
MSN/HA, cells were washed twice with PBS, collected by tripsynization and finally re-suspended 19 
in 1 ml of PBS. Then the intracellular uptake of MSNs was analyzed using a FACScan. Detection 20 
of FITC-MSNs green fluorescence (FL-1) was performed on at least 5,000 events per samples, 21 
using the CellQuest software (Becton-Dickinson, Milano, Italy). Cells incubated in the absence of 22 
MSN were used as control. 23 
 24 
3. Results and discussion 25 
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All samples were characterized about their general properties, The general properties of all samples, 1 
including textural and morphological features, were analyzed. Sample HA6.4A was discarded due 2 
to low derivatization yield and to scarce dispersity (see later), and will thus not be described in 3 
detail in the following. The NH2-MSN sample used for HA conjugation was measured for 4 
comparison. Corresponding results are hereafter discussed only when relevant. 5 
 6 
3.1 Effect of conjugation on porous structure 7 
MSN/HA samples are composed by spherical nanoparticles (particle size 94±20 nm, see 8 
corresponding histogram as Figure S1), which are characterized by an ordered pore structure with 9 
the typical hexagonal array of MCM-41-like materials. This can be appreciated in the high 10 
resolution TEM picture of sample NH2-MSN, reported in Fig 1a, showing two superimposed 11 
particles with pores parallel and perpendicular to the image plane (circle and hexagon shapes, 12 
respectively). The same particle size, morphology and ordered porosity is are preserved after HA 13 
conjugation, as shown in Figures 1b-d. However, in this case an amorphous-like external layer is 14 
clearly observed, which can be attributed to the formation of a shell of HA, covering the particles. 15 
The formation of a HA shell is supported by both qualitative and quantitative characterization 16 
results, described in the following. 17 
The ordered pore structure of the materials is also reflected in the typical XRD pattern, 18 
characterized by low angle peaks at 2.3, 4.0 and 4.7° (Figure S2). These can be labelled as (100), 19 
(110) and (200) in the P6mm symmetry group, corresponding to the a hexagonal pore array of 20 
pores. After HA conjugation, in all samples the peaks decrease in intensity and move to slightly 21 
higher 2q values in all samples. The change is in the order HA200A < HA6.4B @ HA200B. Both 22 
phenomena are usually observed in MCM-41-like materials after functionalization and/or drug 23 
encapsulation, and are interpreted in terms of molecules filling/lining the pores [50, 51]. 24 
Particularly, the d100 parameter, which is the distance between planes passing through the pores 25 
15 
 
centre (see Figure S3), can be calculated from the Bragg equation, as resumed in Table 1. These 1 
data are further discussed hereafter in combination with results from gas-volumetric analysis.  2 
The nitrogen adsorption/desorption isotherms of the three MSN/HA and parent NH2-MSN materials 3 
are reported in Figure 2 (top panel), with the corresponding pore size distribution calculated with 4 
the BJH method (bottom). Curves a) and b), corresponding to NH2-MSN and HA200A, can be 5 
classified as type IV, typical of mesoporous materials. Namely, a steep increase of the adsorbed 6 
amount is observed below p/p0 = 0.3, which corresponds to the capillary condensation of the 7 
adsorbate inside the pores. The narrow hysteresis loop present in all samples at p/p0 reaching 1 is 8 
instead related to condensation of nitrogen in the interparticle porosity. After conjugation, the 9 
nitrogen adsorbed amount decreases in the order HA200A > HA6.4B @ HA200B, and in the latter 10 
last two the capillary condensation related to mesopores filling is no more present. This is reflected 11 
in the corresponding pore size distribution curves (Figure 2, bottom panel). Parent NH2-MSN 12 
material shows an intense and relatively narrow peak centred around 30 Å, corresponding to the 13 
pores lined with aminopropyl groups. This peak is weaker and shifted to lower values for HA200A, 14 
very weak and not present for in HA6.4B and HA200B, respectively. 15 
The textural parameters obtained from these data are summarized in Table 1. On the whole, we 16 
observe a major effect of conjugation on samples prepared by method B, where Specific Surface 17 
Area (SSA), pore volume and diameter are sensibly decreased. This suggests that during this 18 
procedure (where HA activation is carried out directly in the presence of the nanoparticles) the 19 
polymer is not only forming an external layer but it is also diffusing inside the pores. This is less 20 
likely in the case of high molecular weight HA, where the polymer could mainly block pores 21 
entrance not allowing nitrogen molecules to diffuse within during BET measurements. On the other 22 
hand, method A, where HA activation is carried out before reaction with NH2-MSN, results in a 23 
minor diffusion inside the pores, which are less obstructed to the diffusion of the nitrogen adsorbate 24 
used for gas-volumetric analysis. These considerations are in very good agreement with XRD and 25 
TEM observations, showing an apparently thicker HA layer on sample HA200B with respect to the 26 
16 
 
other two (compare Figure 1b with c and d). Finally, the mean pore diameter calculated by BJH 1 
method was combined with the a parameter calculated from XRD (distance between centres of the 2 
pores, see Figure S3), to calculate the apparent wall thickness. The values, summarized in last 3 
column of Table 1, clearly show an increase in the order HA200A < HA6.4B @ HA200B, in 4 
agreement with the above considerations. 5 
 6 
3.2 Quantitative HA analysis 7 
Quantification of HA bonded covalently linked to the NH2-MSN particles was carried out by two 8 
independent techniques, namely TGA and the carbazole colorimetric test. 9 
TGA was carried out from 30 to 1000 °C in air flow, in order to quantify the amount of organic 10 
groups anchored to the silica surface. This was calculated on the basis of the observed weight loss, 11 
normalized to the dry mass of the sample, i.e. after removal of physisorbed water around 100 °C 12 
(Figure S4). All MSN/HA samples show a consistent weight loss between ca 180 and 650 °C, 13 
which is higher with respect to parent NH2-MSN, in the order HA200A < HA200B @ HA6.4B. The 14 
calculated amounts are summarized in Table 2. More details about the criteria used for 15 
quantification can be found in the Supplementary Material. In this context, it is sufficient to 16 
mention that samples HA200B and HA6.4B show very similar weight losses and curves slope, 17 
while HA200A has an intermediate profile, both in terms of quantity and curve shape, in very good 18 
agreement with the trends observed with textural and structural techniques, as described above. 19 
Carbazole colorimetric test was also employed for HA quantification. As mentioned above, HA is a 20 
high molecular weight glycosaminoglycan, formed by a repeating disaccharide unit composed by D-21 
glucuronic acid and N-acetyl-D-glucosamine. In this test HA is hydrolyzed in acid environment, so 22 
that monosaccharide units can form coloured adducts with carbazole through their glucuronic acid 23 
residues. This allows the quantification of HA through a simple optical measurement. 24 
The values obtained with both techniques are resumed in Table 2, expressed as HA weight 25 
percentage. First of all, we underline the very good agreement between the two techniques. 26 
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Secondly, the results show that a definitely higher mass of HA has been linked to MSN with 1 
method B, irrespective of its molecular weight. Method A definitely yields a materials with lower 2 
(around one third) HA loading. This could be explained by the fact that in the latter case HA 3 
activation was carried out before reaction with NH2-MSN. On the basis of gas-volumetric and TEM 4 
results, we infer that this could result in a more difficult diffusion inside the pores, so that mainly 5 
external aminopropyl groups were involved in the reaction. Finally, these results contribute to the 6 
interpretation of the structural and textural parameters of the MSN/HA samples, which appear to be 7 
mainly affected by the HA loading, irrespective of its molecular weight. 8 
 9 
3.3 Qualitative HA analysis: infrared spectroscopy 10 
Infrared spectroscopy is a powerful tool to investigate interface interactions in hybrid organic-11 
inorganic materials. It can be used to assess the molecular structure of surface grafted 12 
functionalizing groups, and the weak interactions taking place between silica surface and 13 
adsorbed/encapsulated drug molecules [28, 50-58]. The spectra of parent NH2-MSN and HA 14 
conjugated samples are reported in Figure 3, in the high and low frequency ranges (top and bottom 15 
panel, respectively). All samples were measured in transmission mode on self-supporting pellets, 16 
after RT evacuation necessary to remove adsorbed impurities and water, which would influence the 17 
spectral analysis (see for instance Refs. [28] and [57]). The spectrum of HA 200 kDa (measured in 18 
KBr) is reported for comparison in the Supplementary Material (Figure S5). The bands assignment 19 
discussed in the following is resumed in Table 3. 20 
The spectrum of parent NH2-MSN sample, reported for comparison, is similar to what already 21 
reported and discussed in the literature [28, 57]. Namely, it is characterized by a broad signal in the 22 
high frequency region (top panel), which is characteristic of hydrogen bonding interactions among 23 
surface Si-OH groups (silanols) and between these and the grafted aminopropyl functionalities. The 24 
presence of the aminopropyl groups is testified by the components bands (superimposed to the 25 
broad band described above) at 3370 and 3300 cm-1 (antisymmetric and symmetric NH2 stretching 26 
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modes, nNH2, respectively) and at 2930/2870 cm-1 (antisymmetric and symmetric nCH2). The very 1 
weak peak at 3734 cm-1 is related to hydrogen bonding acceptors and/or germinal geminal -Si(OH)2 2 
silanols, which were not consumed by the grafting reaction [57]. The corresponding fingerprints of 3 
aminopropyl functional groups in the low frequency region (bottom panel of Figure 3) are the band 4 
at 1595 cm-1 due to the NH2 bending mode (dNH2) and the weak dCH2 features between 1500 and 5 
1320 cm-1. 6 
The spectra of MSN/HA samples show interesting differences with respect to parent materials. 7 
Namely, in the high frequency region an increase in the intensity and spectral breadth of the 8 
absorption between 3700 and 2200 cm-1 is observed, in the order HA200 < HA200 B @ HA6.4B. 9 
This can be clearly related to the presence of an extended hydrogen bonding network, both among 10 
HA residues and between them and the silica surface. Indeed, the weak band at 3734 cm-1 related to 11 
Si-OH groups is consumed, confirming the involvement of surface silanols in hydrogen bonding 12 
interactions with HA. 13 
Moreover, weak components bands can be also observed between 3200 and 3000 cm-1, recalling the 14 
typical spectral shape of hydrogen-bonding carboxylic acids. This indicates that not all the D-15 
glucuronic acid residues were involved in the formation of an amidic bond with the amino groups 16 
present on silica. In agreement with the structural, textural and quantitative data discussed above, 17 
the two samples prepared by method B are very similar and more affected by conjugation, at 18 
variance with sample HA200A, showing an intermediate behavior. 19 
The same trend is observed in the low frequency range (Figure 3, bottom panel). More in detail, 20 
broad absorptions develop in the 1700 – 1500 cm-1 and 1450 - 1350 cm-1 ranges, with the same 21 
order of intensity described above, i.e. HA200 < HA200 B @ HA6.4B. The dNH2 signal at 1595 cm-22 
1 is clearly evident on sample HA200A, and as while it is only a shoulder in the other samples. This 23 
indicates that not all aminoproyl functionalities reacted with HA, as expected for functional groups 24 
lining the inner surface of the pores. Interestingly, the intensity of this band is higher on sample 25 
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HA200A, where a lower diffusion of HA residues inside the pores was inferred from textural and 1 
structural analysis (see above). 2 
Concerning the new spectral features developing in this spectral region after HA conjugation, they 3 
can be safely ascribed to the formation of an amidic bond between the NH2-MSN amino groups and 4 
the carboxylic acid functionalities of HA. Namely, the amide I band (nCO) is observed at 1650 cm-5 
1, the amide II (dNH and nCN combination mode) at 1550 cm-1, while the absorption between 1430 6 
and 1350 cm-1 is related to the numerous dCH and dOH vibrations of HA.  7 
 8 
3.4 Interaction with water molecules 9 
HA is a hydrophilic macromolecule, with interesting applications as wetting agent [59-61] or as 10 
polymer for surfaces modification. Indeed, recent studies reported about the use of HA to improve 11 
hydrophilicity and biocompatibility of chitosan films or scaffolds [62, 63]. Moreover, HA has been 12 
used to increase surfaces hydrophilicity to provide antifouling properties, as a result of reduced 13 
nonspecific protein adsorption [64-68]. In this work, the effect of HA conjugation on the 14 
hydrophilic character of MSN has been studied by carrying out water vapour sorption 15 
microgravimetric experiments. This technique has been recently employed by some of us to 16 
investigate the effect of different functional groups on the hydrophilic character of MSN [28]. 17 
Water adsorption/desorption isotherms at 28 °C were measured on the three MSN/HA, by gradually 18 
increasing the equilibrium vapour pressure in the 0- 20 mbar range (p/p0 from 0 to ca 0.55). The 19 
results obtained on sample HA6.4B are reported in Figure 4 (top panel). Similar trends were 20 
observed on samples HA200A and HA200B (see Figure S6) and can be summarized as follows. 21 
Both primary and secondary adsorption/desorption cycles are characterized by a hysteresis loop, 22 
with higher water uptake measured during the desorption step, for each p/p0 value. This can be 23 
explained by the slow diffusion of water interacting with the external HA layer surrounding the 24 
MSN. This implies that the equilibrium is probably not reached in the adsorption step within the 25 
time frame of the experiment (timeout of 60 minutes for each p/p0 dosage). A small water amount is 26 
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not desorbed after the first desorption step, and in all samples the second cycle results in a slightly 1 
higher water uptake. When comparing the secondary desorption curves on the three MSN/HA 2 
samples, the following order of water uptake is observed: HA6.4B > HA200A @ HA200B (Figure 3 
4, bottom panel). 4 
The obtained results are at first sight surprising, when compared to what measured on the parent 5 
NH2-MSN material, where a maximum uptake of  6.7 wt% (3.7 mmol/g) was measured at p/p0@ 0.3 6 
and 25 °C [28]. This is sensibly higher with respect to what obtained on the MSN/HA samples (1.3-7 
1.7 wt%, see Table 4), indicating a decrease of in the water uptake of MSN after HA conjugation, in 8 
contrast to what expected for the high hydrophilicity of the polysaccharide. However, the 9 
explanation of this apparently puzzling results can be found through a more detailed analysis of the 10 
measured isotherms. To this aim, the primary and secondary desorption curves of the samples have 11 
been fitted with a Langmuir model, assuming that they are closer to the thermodynamic equilibrium 12 
with respect to adsorption ones. The results from this analysis are summarized in Table 4, together 13 
with the results for NH2-MSN parent sample (data from Ref. [28]). First, we acknowledge the fact 14 
that for all HA conjugated samples the agreement with the Langmuir model is satisfactory (R2> 15 
0.99), which is not the case for NH2-MSN (R2 = 0.9267 for both cycles). Secondly, the set of 16 
calculated K values (corresponding to the equilibrium constant of the adsorption process) are 17 
consistent for the set of samples, ranging from 17 to ca 23, while for NH2-MSN a value around 8.5 18 
was found for both sorption cycles. These data clearly indicates that on the conjugated samples 19 
water is mainly interacting with the external HA layer, where it is strongly adsorbed and cannot 20 
freely diffuse inside the MSN pores, at least in the time frame and experimental conditions of the 21 
experiment. This picture fits well with the higher K values and smaller uptake with respect to parent 22 
NH2-MSN.  23 
Coming back to the comparison among the three samples (Figure 4, bottom panel) the calculated K 24 
values are in the order HA200A < HA200B < HA6.4B. The last samples being the one with the 25 
highest uptake, we can infer that the polysaccharide molecular weight influences its hydrophilicity. 26 
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On the contrary, water uptake on HA200A is almost identical to HA200B, irrespective of the 1 
different loading. This supports the idea that, when dosed from vapour phase, water is strongly 2 
adsorbed on the external HA layer with limited diffusion within the pores. This effect could limit 3 
the diffusion of drugs to and from the material pores, as indicated by preliminary studies on drug 4 
loading carried out in our group (not reported). Noticeably, samples HA200B and HA6.4B shows a 5 
similar water/HA weight ratio (ranging from 0.07 to 0.09) with respect to the sample prepared by 6 
method A (0.21-0.22). These data further support the picture obtained by characterization 7 
techniques, indicating that sample HA200A is characterized by a different distribution of HA at the 8 
pores entrance, with a consistent amount of unreacted amino groups. This could indicate an easier 9 
diffusion of adsorbates (such as water molecules) and host drug molecules within the sample. 10 
 11 
3.3 Effect of HA on surface charge, aggregation and dispersity 12 
The electrophoretic mobility of the materials was measured to evaluate the effect of conjugation on 13 
the particles z potential, which gives an indirect information about the surface charge in the Stern 14 
layer. This parameter is affected by both the hydrodynamic diameter and the electric double layer 15 
thickness, the latter being strongly influenced by the fluid ionic strength and pH. An estimation of 16 
the double layer thickness as a function of the ionic strength can be used in the Henry equation, to 17 
convert electrophoretic mobility into z potential values [69]. However, in this work z potential 18 
values (summarized in Table 2) were calculated with the Smoluchowski equation (representing an 19 
approximation valid for thick double layers), for direct comparison with the literature works in the 20 
field [28, 70-73]. 21 
In aqueous solution, the amine group is positively charged while the carboxylic ones of HA show a 22 
negative charge in relation to their pKa. Assessing the pKa of both covalently linked HA external 23 
layer and aminopropyl groups is not straightforward, since both systems are intrinsically complex. 24 
Indeed the pKa of amino-functionalized hybrid materials is has been the subject of extensive 25 
research work, since the covalent bond and interactions with the inorganic surface can affect the 26 
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amino basicity [28, 57, 74-78]. In our work, z potential values in water change depending on the 1 
amount and on the molecular weight of the conjugated HA. At equal HA molecular weight 2 
(compare HA200A and HA200B, 2nd and 3rd lines in Table 2), the z potential decreases as the 3 
amount of HA increases. Namely, HA200A (HA loading 6.6 wt%) shows a small but positive value 4 
(+14.3 ± 1.3 mV), while HA200B, with a HA loading almost triple is characterized by a negative z 5 
potential (-19.8 ± 1.9 mV). Samples obtained by method B showed a more negative surface charge; 6 
in fact, according to TGA and carbazole test, this method allows a more efficient conjugation.  7 
Considering the different HA molecular weights of samples obtained by the same conjugation 8 
method, HA200B showed a more negative surface charge with respect to HA6.4B, without clear 9 
correlation with the HA loading. Measurements were also carried out on sample HA6.4A, which 10 
was discarded for a more detailed characterization because of low HA loading (3.1 wt% as 11 
measured by carbazole test, see Table 2) and scarce dispersity (see below). Indeed, this sample 12 
shows a z potential value in water almost identical to NH2-MSN, in agreement with the low 13 
derivatization yield.  14 
When the same measurements are carried out in PBS, a different trend is observed, in that almost 15 
all samples show more negative z potential values. As recently reported, buffer ions can strongly 16 
affect adsorption phenomena at the solid-liquid interphase of charged nanoparticles [73, 79, 80]. 17 
Marucco et al. pointed out how adsorption of phosphate ions from the buffer solution can influence 18 
the particles surface properties and charge [79]. On the other hand, we cannot exclude the 19 
competition of chloride (and Na+ and K+ cations, although at a lesser extent) in modifying the 20 
effective surface charge of MSNs, in agreement with the work by Cugia et al. [73]. Indeed, in our 21 
work all the three considered HA conjugated samples show a similar negative z potential value 22 
(around -16 mV), irrespective of the values measured in water. On the contrary, parent NH2-MSN 23 
still shows a positive (though minor) charge and sample HA6.4A is almost neutral (-1.3 ± 0.5 mV). 24 
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These results cannot easily be rationalized due to the complex interactions of buffer ions with 1 
nanoparticles [73]. 2 
DLS measurements were carried out to estimate the hydrodynamic sizes of all samples in both 3 
water and PBS (Table 2). The average values are always higher than the size of the single particles 4 
measured by TEM, indicating agglomeration. A slight decrease in the size is observed after HA 5 
conjugation, particularly for high molecular weight and loading, indicating a positive effect of the 6 
polymer against the MSNs tendency to agglomeration. Since our attention is focused on the 7 
possibility to use these systems for pharmaceutical application, we have followed the evolution of 8 
the hydrodynamic size with time. Figure 5 shows the results obtained on the more stable samples in 9 
PBS, i.e. HA6.4B, HA200A and HA200B. All The samples show a slight increase of dimensions in 10 
the first hours, and then reach a stable value, apart from sample HA6.4B which is characterized by 11 
larger size and lower stability. These observations are reflected in the dispersity tests described 12 
below. 13 
The pictures acquired during dispersity tests in PBS are shown in Figure 6. In this case a higher 14 
concentration was used (2 mg/ml vs 0.08 mg/ml used for both z potential and DLS measurements), 15 
for easier visual observation. The samples with HA of higher molecular weight were better 16 
dispersed with respect to parent NH2-MSN and HA6.4B, which started to precipitate after 4 h. On 17 
the contrary, dispersity was dramatically improved after conjugation with high molecular weight 18 
HA: HA200A and HA200B formed a stable suspension in PBS for more than 24 h. The enhanced 19 
stability of these samples can be explained on the basis of their steric hindrance and of the 20 
electrostatic repulsion among the stretched hydrophilic HA chains, reducing the possibility of 21 
agglomeration and precipitation. Finally, as concern sample HA6.4A, its precipitation is already 22 
complete already after 4 hours, in agreement with a z potential value close to zeromeasured almost 23 
zero charge. The dispersity tests carried out in DMEM +10% FBS showed a similar trend (data not 24 
reported). 25 
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These data confirm the working hypothesis that HA conjugation is a simple and effective method 1 
for improving the dispersity and stability of the nanoparticles, which is in turn beneficial for blood 2 
circulation making the further intravenous injection possible. Moreover, our study points out how, 3 
irrespective of the similar measured z potential, which is influenced by the chemical nature of the 4 
buffer medium, the molecular weight of the conjugating macromolecule has a strong influence on 5 
dispersity.  6 
 7 
3.4 Biological characterization 8 
3.4.1. Analysis of cell surface CD44 expression 9 
The HA receptor CD44, an ubiquitous transmembrane molecule, is expressed at low levels on the 10 
surface of several normal cells and overexpressed in many cancer cells [81]. The levels of receptor 11 
cell surface expression were preliminary evaluated on a panel of cancer cell lines (MDA-MB-231, 12 
JR8, A459, MCF7 and A2780) using anti-CD44 antibody and flow cytometry, with the aim to 13 
identify the cell models to be used for further in vitro studies. The results show that A2780 cells did 14 
not express detectable amount of CD44 whereas MDA-MB-231 cells display a very high 15 
expression (Figure 7). Thus, to evaluate the cytotoxic activity and the cellular uptake of the 16 
nanoparticles, MDA-MB-231 and A2780 cells were chosen as CD44+ and CD44- cancer cells, 17 
respectively. 18 
 19 
3.4.2 In vitro cytotoxicity 20 
The in vitro cytotoxicity of NH2-MSN and MSN/HA was evaluated after treatment of 24, 48 and 72 21 
h in the concentration range of 1.5-25 µg/ml. and The results showed that the nanoparticles were 22 
non-toxic for both cell lines demonstrating the good safety and biocompatibility of the carriers (data 23 
not shown). These data are in agreement with the results obtained with other HA decorated MSN 24 
[24, 36, 37, 40]. 25 
 26 
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3.4.3 In vitro targeting analysis 1 
Efficient cellular uptake is a major requirement for the therapeutic efficacy of nanoparticles 2 
targeting. To test the targeting ability of our MSN we evaluated the cellular uptake of both FITC-3 
labelled NH2-MSN and MSN/HA on MDA-MB-231 (CD44+) and A2780 (CD44-) cell lines by 4 
both CLSM and FACS. 5 
CLSM allowed us to visualize visualizing the cellular uptake and biodistribution of the 6 
nanoparticles by in these two cell lines. As shown in Figure 8, in both cell lines MSN occurred in 7 
the cytoplasm as clusters of different size; accordingly, previous TEM studies at transmission 8 
electron microscopy demonstrated that these nanoparticles are internalized by the cell via both 9 
endocytosis and phagocytosis, and then accumulate into cytoplasmic vacuoles [82]. Moreover, 10 
MSNs were never found inside the nucleus of MDA-MB-231 and A2780 cells, consistently with 11 
previous observations in the same or in different cell lines treated with these nanoparticles [23, 24, 12 
40, 82-85]. Although CLSM does not allow precise quantitation of cellular uptake, the amount of 13 
internalized NH2-MSN was apparently similar in the two cell lines, whereas HA6.4B and HA200B 14 
were more abundant in MDA-MB-231 than in A2780 cells. This suggests that MSN/HA possess 15 
significant selectivity for cells overexpressing CD44 receptors, consistently in agreement with our 16 
results obtained with flow cytometry (see below).  17 
In addition, microscopic observation of the samples revealed the absence of evident morphological 18 
alterations in both cytoplasm (e.g. vacuolization) and nucleus (e.g. pyknosis, apoptosis), thus 19 
confirming the high biocompatibility of NH2-MSN and MSN/HA at the concentrations tested in this 20 
study. 21 
The morphological images obtained by CLSM are consistent with the flow cytometry analysis 22 
performed in order to obtain a quantitative comparison between FITC labelled NH2-MSN and 23 
MSN/HA nanoparticles characterized by different preparation methods and different HA molecular 24 
weight (Fig. 9). After treating A2780 and MDA-MB-231 cells with the different MSN/HA, their 25 
uptake in A2780 cells is moderately increased in a time dependent depending manner, but almost 26 
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irrelevant in comparison with MDA-MB-231 (Fig. 9A). In particular, the FITC mean intensity of 1 
MSN/HA200 (both A and B) was dramatically increased in MDA-MB-231 in comparison to A2780 2 
(Fig. 9A, B). Concerning MDA-MB-231, we observed that the cellular uptake efficiency is 3 
increased over incubation time (up to 1h, when the uptake is near plateau, approximately 80%, Fig. 4 
9C). Moreover, the cellular uptake efficiency is also dependent on the amount of HA on 5 
nanoparticles surface and on its molecular weight. In particular, we obtained a higher uptake of 6 
HA200B versus HA200A, demonstrating that the method B in which the activation of HA was 7 
carried out directly in the presence of the nanoparticles, improves cells uptake (Fig. 9B). In 8 
contrast, the mean intensity of FITC from the cells incubated with FITC labelled NH2-MSNs 9 
without HA modification is lower and similar for both cell lines. These in vitro experiments 10 
confirm that MSN/HA can target CD44 over-expressing MDA-MB-231 cancer cells via the HA 11 
receptor-mediated endocytosis [84, 86] and phagocytosis [87] pathways, strongly highlighting the 12 
potential use of MSNs/HA as more an efficient approach for tumor-targeting treatments. 13 
 14 
Conclusions 15 
MSN/HA samples were prepared following two different conjugation procedures previously 16 
reported [36, 37] and using HA of two different molecular weight (6.4 and 200 kDa). The size of 17 
HA strongly affects its biological functions and its physico-chemical characteristics [35]. However, 18 
to our knowledge this is the first time that such a comparative study is reported, helping the 19 
scientific community working in the field to select the best strategy to obtain hybrid nanomaterials 20 
with good biological response and potential pharmaceutical applicability. More in detail, our 21 
systematic physico-chemical analysis points to the concerted effect of both HA molecular weight 22 
and loading on MSN in improving dispersity of MSN. With this respect, we have demonstrated that 23 
the ‘one pot’ method - in which HA is directly activated in the presence of the nanoparticles – is the 24 
most efficient, also in terms of possible scale-up. 25 
27 
 
Our results are also in agreement with recent reports about the importance of considering the 1 
interaction of buffer ions with nanoparticles when assessing surface charge and related interphase 2 
phenomena, which are of fundamental importance to rationalize results in physiological media [73]. 3 
Finally, in vitro tests on cancer cell lines demonstrated that MSN/HA are biocompatible and 4 
preferentially target cells overexpressing the HA receptor CD44. Also in this context, the best 5 
performances are obtained with the ‘one pot’ sample prepared using HA with high molecular 6 
weight (HA200B). All these data suggest the potential use of MSNs/HA as a more efficient 7 
approach for tumor-targeting treatments.  8 
 9 
Acknowledgements 10 
Funding from Italian Ministry for University and Research (MIUR)—University of Turin, “Fondi 11 
Ricerca Locale (ex-60%)” are kindly acknowledged. We thank Maria Carmen Valsania (Mayita) 12 
from Department of Chemistry and NIS Centre, University of Torino, for TEM measurements. 13 
  14 
28 
 
Figure captions 1 
Fig. 1 HRTEM images of a) NH2-MSN; b) HA200A; c) HA200B and d) HA6.4B 2 
 3 
Fig. 2 Nitrogen gas-volumetric adsorption (crosses) and desorption (squares) isotherms (top) and 4 
pore size distributions (bottom) of a) NH2-MSN; b) HA200A; c) HA200B and d) HA6.4B 5 
 6 
Fig. 3 Infrared spectra in the high and low frequency regions (top and bottom panels, respectively) 7 
of NH2-MSN (black); HA200A (blue); HA200B (red) and HA6.4B (green). Spectra were measured 8 
on dehydrated samples and are normalized with respect to pellet thickness 9 
 10 
Fig. 4 Water microgravimetric isotherms measured at 28 °C on MSN/HA samples. Top: primary 11 
and secondary adsorption/desorption measurements on sample HA6.4B; bottom: comparison of 12 
secondary desorption measurements on HA200A (◄), HA200B (■) and HA6.4B (●). 13 
 14 
Fig. 5 Dynamic light scattering data of HA200A (blue); HA200B (red) and HA6.4B (green) in PBS 15 
measured at 0, 4, 8, 24 and 30 h. The error bars represent the standard deviation of three 16 
measurements. 17 
 18 
Fig. 6 Images of NH2-MSN, HA6.4A, HA200A, HA6.4B and HA200B dispersed in PBS with a 19 
concentration of 2 mg/ml measured at 0, 4, 8, 24 and 30 h. 20 
 21 
Fig. 7 Flow cytometric histograms of CD44 expression in A2780 cells and MDA-MB-231 cells. 22 
Red lines: anti-CD44 antibody; blue lines: isotype control. 23 
 24 
Fig. 8 Confocal micrographs of A2780 cells (a-c) and MDA-MB-231 cells (d-f) after 24h 25 
incubation with different MSN (green fluorescence): NH2-MSN (a and d), HA6.4B (b and e) and 26 
29 
 
HA200B (c and f). All MSN are distributed in the cytoplasm but are absent from the nucleus (blue 1 
fluorescence). The cytoplasm is counterstained with trypan blue (red fluorescence). Note the higher 2 
amount of MSN in e and f. Bars: 10 µm. 3 
 4 
Fig. 9 Cellular uptake of FITC labelled NH2-MSN with or without HA modification in A2780 and 5 
MDA-MB-321 cell lines. Analysis of internalization of NH2-MSN, HA6.4B, HA200A and 6 
HA200B in A2780 (A) and MDA-MB-231 (B,C) cells by flow cytometry for the indicated time. 7 
Data in graphs are expressed as means ± SEM (*p< 0.05  and ** p<0.01 vs FITC-NH2-MSN) of 8 
three independent experiments. 9 
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Tables 1 
 2 
 3 
Table 1: Textural and structural properties of the studied materials 4 
Samples 
SSA 
 (m2/g) 
Mesopores 
volume 
(cm3/g) 
Mean 
diameter  
(Å) 
d100 (Å) a (Å) 
Wall  
thickness 
 (Å) 
NH2-MSN 789 1.18 30 38.21 44.12 14 
HA200A 494 0.91 26 37.88 43.74 18 
HA200B 204 0.33 <20 36.32 41.94 >22 
HA6.4B 222 0.60 ≈22 36.78 42.47 20 
 5 
 6 
 7 
Table 2: Quantitative analysis, and z potential and mean hydrodynamic diameter 8 
Samples HA loading (wt%) z potential (mV) Mean hydrodynamic diameter (nm) 
TGA Carbazole water PBSa water PBSa 
NH2-MSN - - +35.0 ± 0.9 +12.4 ± 0.7 360.7 ± 11.2 409.3 ± 23.0 
HA200A 6.6 8.1 +14.3±1.3 -16.5 ± 0.8 292.7 ± 10.6  309.0 ± 18.2 
HA200B 17.4 19.9 -19.8 ± 1.9 -15.7 ± 0.9 253.1 ± 10.5 265.9 ± 20 
HA6.4A n. d. 3.1  +34.5 ± 0.1 -1.3 ± 0.5 313.8 ± 8.4 389.2 ± 13.0 
HA6.4B 19.0 18.9 -8.8 ± 0.7 -16.8 ± 0.8 301.9 ± 12.1 354.7 ± 16.1 
n. d.: not determined; a 0.1 M, pH = 7.4 9 
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Table 3. Main infrared assignments 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
Table 4: Langmuir parameters for water vapour sorption process 11 
Samples 
1st cycle 2nd cycle 
qm (wt%) K R2 qm (wt%) K R2 
NH2-MSN a 6.83 8.47 0.9267 9.23 8.47 0.9267 
HA200A 1.37 17.10 0.9932 1.47 18.29 0.9940 
HA200B 1.28 20.14 0.9964 1.43 19.47 0.9964 
HA6.4B 1.56 20.87 0.9950 1.66 22.82 0.9968 
a Parameters calculated from data measured at 25 °C (from Ref. [28]) 12 
 13 
 14 
  15 
High frequency Low frequency 
Position Assignment Position Assignment 
3370 cm-1 ν asym NH2 1650 cm-1 nC=O (Amide I) 
3300 cm-1 ν sym NH2 1595 cm-1 δ NH2 (aminoproyl) 
2930 cm-1 ν asym CH2 1550 cm-1 δNH/nC-N comb. (Amide II) 
2870 cm-1 ν sym CH2 1430-1350 cm-1 dCH and δOH 
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